Related scientific articles (all)

DNA methylation profiling reveals a predominant immune component in breast cancers.

Authors : Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, Lallemand F, Larsimont D, Toussaint J, Haussy S, Rothé F, Rouas G, Metzger O, Majjaj S, Saini K, Putmans P, Hames G, van Baren N, Coulie PG, Piccart-Gebhart M, Sotiriou C, Fuks F
Year : 2011
Journal : EMBO Mol Med
Volume : 3(12)
Pages : 726-41

Multifactorial approach to predicting resistance to anthracyclines.

Authors : Desmedt C, Di Leo A, de Azambuja E, Larsimont D, Haibe-Kains B, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L
Year : 2011
Journal : J. Clin. Oncol.
Volume : 29(12)
Pages : 1578-86

The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.

Authors : Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2011
Journal : Cell. Immunol.
Volume : 270(2)
Pages : 207-16

Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Authors : Firescu R, Muylle K, Roelandts M, de Wind A, Moerman C, Lemort M, Kentos A, Meuleman N, Bron D
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 83-92